{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:23:20Z","timestamp":1788927800306,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.593143","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T07:10:26Z","timestamp":1604992226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism"],"prefix":"10.3389","volume":"11","author":[{"given":"Beatrice","family":"Roiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pigato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1994.tb05859.x","article-title":"Compliance with antipsychotic drug treatment: influence of side effects","volume":"382","author":"Fleischhacker","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"B2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00004714-200004000-00011","article-title":"Tardive dyskinesia associated with higher mortality in psychiatric patients: results of a meta-analysis of seven independent studies","volume":"20","author":"Ballesteros","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e25588","DOI":"10.1371\/journal.pone.0025588","article-title":"Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder","volume":"6","author":"Bakker","year":"2011","journal-title":"PLoS ONE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0920-9964(95)00096-8","article-title":"The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia: the Cura\u00e7ao Extrapyramidal Syndromes Study: I","volume":"19","author":"Van Harten","year":"1996","journal-title":"Schizophr Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/jamaneurol.2019.3446","article-title":"Risk of developing Parkinson disease in bipolar disorder: a systematic review and meta-analysis","volume":"77","author":"Faustino","year":"2019","journal-title":"JAMA Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7130","article-title":"A systematic review of atypical antipsychotic drugs in schizophrenia","volume":"7","author":"Bagnall","year":"2003","journal-title":"Health Technol Assess"},{"key":"B8","first-page":"9","article-title":"New nomenclature for drug-induced movement disorders including tardive dyskinesia","volume":"65","author":"Chouinard","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00004850-200203000-00006","article-title":"Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports","volume":"17","author":"Schillevoort","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jnnp.2006.100222","article-title":"Movement disorders in patients taking anticonvulsants","volume":"78","author":"Zadikoff","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/acps.12171","article-title":"Lithium tremor revisited: pathophysiology and treatment","volume":"129","author":"Baek","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"B12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP-CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/mds.22098","article-title":"[123I]-FP-CIT SPET imaging in drug-induced parkinsonism","volume":"23","author":"Tinazzi","year":"2008","journal-title":"Mov Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.schres.2013.11.028","article-title":"Imgaing of the dopamine transporter predicts pattern of disease progression and response to levodopa with schizophrenia and parkinsonism: a 2 year follow up multicenter study","volume":"152","author":"Tinazzi","year":"2014","journal-title":"Schizophr Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/mds.26839","article-title":"Incidence and time trends of drug-induced parkinsonism: a 30-year population-based study","volume":"32","author":"Savica","year":"2017","journal-title":"Mov Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mds.10344","article-title":"Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity","volume":"18","author":"Chuang","year":"2003","journal-title":"Mov Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00415-009-0137-6","article-title":"Cyclosporine-induced parkinsonism","volume":"256","author":"Lima","year":"2009","journal-title":"J Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3233\/JPD-140414","article-title":"Iatrogenic parkinsonism: the role of flunarizine and cinnarizine","volume":"4","author":"Miguel","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S1474-4422(05)70226-X","article-title":"Prevalence of movement disorders in men and women aged 50\u201389 years (Bruneck Study cohort): a population-based study","volume":"4","author":"Wenning","year":"2005","journal-title":"Lancet Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0920-9964(99)00133-4","article-title":"Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia","volume":"42","author":"Modestin","year":"2000","journal-title":"Schizophr Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.161.1.160","article-title":"Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients","volume":"161","author":"Janno","year":"2004","journal-title":"Am J Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0072-9752(07)84051-6","article-title":"Drug-induced parkinsonism","volume":"84","author":"Micheli","year":"2007","journal-title":"Handb Clin Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: incidence, management and prevention","volume":"29","author":"L\u00f3pez-Send\u00f3n","year":"2012","journal-title":"Drugs Aging"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T07:10:28Z","timestamp":1604992228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":24,"alternative-id":["10.3389\/fneur.2020.593143"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.593143","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"article-number":"593143"}}